CINECA IRIS Institutional Research Information System

PASQUALETTI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.086
AS - Asia 1.248
EU - Europa 1.137
SA - Sud America 188
AF - Africa 131
Continente sconosciuto - Info sul continente non disponibili 82
OC - Oceania 2
Totale 5.874
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.009
IT - Italia 505
SG - Singapore 460
CN - Cina 347
SE - Svezia 159
BR - Brasile 153
HK - Hong Kong 152
DE - Germania 121
VN - Vietnam 115
GB - Regno Unito 83
FR - Francia 52
BG - Bulgaria 49
CA - Canada 45
CI - Costa d'Avorio 43
FI - Finlandia 41
IN - India 31
SN - Senegal 25
JP - Giappone 23
AT - Austria 21
BD - Bangladesh 21
NG - Nigeria 21
PL - Polonia 21
TR - Turchia 21
NL - Olanda 19
RU - Federazione Russa 19
ID - Indonesia 15
MX - Messico 11
AR - Argentina 9
MA - Marocco 8
VE - Venezuela 8
CH - Svizzera 7
ES - Italia 7
IQ - Iraq 7
KE - Kenya 7
PK - Pakistan 7
CZ - Repubblica Ceca 6
DZ - Algeria 6
ZA - Sudafrica 6
AZ - Azerbaigian 5
EC - Ecuador 5
JM - Giamaica 5
MY - Malesia 5
UA - Ucraina 5
BE - Belgio 4
CR - Costa Rica 4
PH - Filippine 4
UZ - Uzbekistan 4
BB - Barbados 3
BO - Bolivia 3
CL - Cile 3
CY - Cipro 3
EE - Estonia 3
IL - Israele 3
KZ - Kazakistan 3
LT - Lituania 3
MG - Madagascar 3
PE - Perù 3
SA - Arabia Saudita 3
TW - Taiwan 3
BH - Bahrain 2
CO - Colombia 2
DO - Repubblica Dominicana 2
EG - Egitto 2
ET - Etiopia 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
JO - Giordania 2
NP - Nepal 2
RS - Serbia 2
TN - Tunisia 2
AD - Andorra 1
AL - Albania 1
AO - Angola 1
AU - Australia 1
BM - Bermuda 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CU - Cuba 1
GA - Gabon 1
GE - Georgia 1
IE - Irlanda 1
KG - Kirghizistan 1
KR - Corea 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
PY - Paraguay 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
UG - Uganda 1
Totale 5.790
Salva come PNG Salva come JPEG
Città #
Ashburn 293
San Jose 256
Singapore 247
Santa Clara 160
Woodbridge 159
Hong Kong 152
Fairfield 151
Dallas 145
Chandler 136
Seattle 89
Beijing 81
Houston 78
Los Angeles 77
Shanghai 71
Wilmington 68
Cambridge 67
New York 62
Pisa 62
Boardman 57
London 56
Munich 53
Sofia 49
Council Bluffs 46
Florence 44
Abidjan 43
Ann Arbor 34
Ho Chi Minh City 32
Serra 30
Turku 28
Dakar 25
Lucca 25
Frankfurt am Main 24
Atlanta 21
Lagos 21
Lauterbourg 21
Hanoi 20
Lawrence 20
Princeton 20
Tokyo 20
Vienna 20
Warsaw 20
Rome 19
São Paulo 19
Milan 18
Buffalo 17
Toronto 17
Istanbul 13
Redondo Beach 13
Bremen 12
Des Moines 12
Medford 12
Pontedera 12
Dong Ket 11
Orem 11
Ottawa 11
Vicopisano 11
Amsterdam 10
Cascina 10
Falls Church 10
Ogden 10
Montreal 9
Chicago 8
Da Nang 8
Düsseldorf 8
Genoa 8
Quanzhou 8
San Francisco 8
Bientina 7
Casablanca 7
Denver 7
Fuzhou 7
Lancaster 7
Massa E Cozzile 7
Nairobi 7
San Diego 7
Stockholm 7
Chennai 6
Curitiba 6
Dearborn 6
Guangzhou 6
Helsinki 6
Manchester 6
Nanjing 6
Palm Bay 6
Paris 6
Zurich 6
Baku 5
Haiphong 5
Olomouc 5
Pietrasanta 5
Porto Alegre 5
Tampa 5
Bari 4
Barletta 4
Brasília 4
Brussels 4
Dhaka 4
Fasano 4
Hillsboro 4
Livorno 4
Totale 3.573
Salva come PNG Salva come JPEG
Nome #
CD80/CD163 macrophage signature identifies high-risk glioblastoma patients 307
Association of Glutathione S-Transferase P-1 (GSTP-1) rs1695 polymorphism with overall survival in glioblastoma patients treated with combined radio-chemotherapy 292
Correction to: Association of XRCC3 rs1799794 polymorphism with survival of glioblastoma multiforme patients treated with combined radio-chemotherapy 270
Association of XRCC3 rs1799794 polymorphism with survival of glioblastoma multiforme patients treated with combined radio-chemotherapy 259
Corrigendum: Metabolic-imaging of human glioblastoma live tumors: a new precision-medicine approach to predict tumor treatment response early 228
Melanocortin Receptor-4 and Glioblastoma Cells: Effects of the Selective Antagonist ML00253764 Alone and in Combination with Temozolomide In Vitro and In Vivo 215
Bevacizumab for the Treatment of Radiation-Induced Cerebral Necrosis: A Systematic Review of the Literature 209
Salvage Hypofractionated Radiotherapy in Combination with Bevacizumab in Patients with Recurrent High Grade Glioma: A Mono-institutional Experience 205
Role of perfusion CT in the evaluation of metastatic nodal tumor response after radiochemotherapy in head and neck cancer: preliminary findings 185
Molecular portrait of a rare case of metastatic glioblastoma: somatic and germline mutations using whole-exome sequencing 182
Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy 181
The role of clinicopathologic and molecular prognostic factors in the post-mastectomy radiotherapy (PMRT): a retrospective analysis of 912 patients 175
EP-1568 Long-term results of [18F] Fluorocholine PET/CT guided SBRT in patients with prostate cancer 175
Non-melanoma skin cancer treated with high-dose-rate brachytherapy: A review of literature 170
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 167
A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer 164
Electron FLASH radiotherapy in vivo studies. A systematic review 163
Different timing to use bevacizumab in patients with recurrent glioblastoma: Early versus delayed administration 163
Dabrafenib treatment in a patient with BRAF V600E ganglioglioma: circulating exosome-derived cancer RNA supports treatment choice and clinical monitoring 156
A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: Clinical benefit is a plausible end point? 154
Impact of recurrence pattern in patients undergoing a second surgery for recurrent glioblastoma 153
Single-agent Bevacizumab in Recurrent Glioblastoma After Second-line Chemotherapy With Fotemustine: The Experience of the Italian Association of Neuro-Oncology 152
The Prognostic Impact of Gender, Therapeutic Strategies, Molecular Background, and Tumor-Infiltrating Lymphocytes in Glioblastoma: A Still Unsolved Jigsaw 150
Metabolic-imaging of human glioblastoma live tumors: A new precision-medicine approach to predict tumor treatment response early 140
Impact of temporalis muscle thickness in elderly patients with newly diagnosed glioblastoma treated with radio or radio-chemotherapy 132
EP-1648 Radio-chemotherapy with temozolomide in elderly patients with glioblastoma: our experience 130
Definitive radiotherapy for recurrent vulvar carcinoma after primary surgery: a two-institutional Italian experience 128
Epileptogenesis and oncogenesis: An antineoplastic role for antiepileptic drugs in brain tumours? 126
Correlation of Pre- and Post-radio-chemotherapy MRI Texture Features With Tumor Response in Rectal Cancer 122
The impact of survivorship bias in glioblastoma research 112
Early Versus Late Postoperative Radiotherapy in Patients With Prostate Cancer: Results of a Single-centre Retrospective Study 90
Decoding the puzzle: A multidisciplinary systematic review of adult brainstem glioma 76
Surgical Management of Adult Brainstem Gliomas: A Systematic Review and Meta-Analysis 72
New perspectives in liquid biopsy for glioma patients 65
Integrating stereotactic radiotherapy and systemic therapies 62
null 46
Brain Stem Glioma Recurrence: Exploring the Therapeutic Frontiers 36
Learning and actioning general principles of cancer cell drug sensitivity 32
Exploring Regorafenib Responsiveness and Uncovering Molecular Mechanisms in Recurrent Glioblastoma Tumors through Longitudinal In Vitro Sampling 30
Totale 5.874
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.252
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.252
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022237 0 0 2 14 59 39 11 11 24 8 17 52
2022/2023546 44 90 51 22 65 59 4 43 113 1 48 6
2023/2024335 15 26 48 35 34 53 13 12 17 25 20 37
2024/20251.204 30 37 11 74 114 148 80 59 125 130 137 259
2025/20261.812 141 164 171 181 245 122 257 88 118 229 56 40
2026/2027745 101 574 70 0 0 0 0 0 0 0 0 0
Totale 5.874